A High-Efficiency and Sustainable Next-Generation Nanotherapeutic platform to Improve Astrocytoma Outcomes

Project Code

MRCNMH26Ca Duc

Project Type

Wet lab

Research Theme

Neuroscience and Mental Health

Project Summary Download

Summary

In 2023, the Welsh and UK Government emphasised the urgent need for a
strategic plan prioritising research in brain tumour therapy. Astrocytoma,
comprising 1/3 of UK brain tumours, impact both children (mainly low-grade) and
adults (can be high-grade e.g. glioblastomas with poor survival), stressing the need
for better treatments and quality of life(QoL). This research aims to develop
innovative functionalized nanocellulose-isothiocyanate nanoparticles drug-
delivery platform (FNP) capable of effectively crossing the blood-brain-
barrier(BBB) due to distinctive electroactive properties and effectively inducing
targeted anti-tumoral effect on astrocytoma cells and favour neural regeneration.
We will also explore electrical stimulation for enhancing FNP drug-delivery
across BBB.

Lead Supervisor

Dr Daniela Duc

Lead Supervisor Email

DucD@cardiff.ac.uk

University Affiliation

Cardiff